Results
|
|
101.
|
|
|
|
102.
|
Transposable elements Ac and Ds at the shrunken, waxy, and alcohol dehydrogenase 1 loci in Zea mays L. [electronic resource] by
- Courage, U
- Döring, H P
- Frommer, W B
- Kunze, R
- Laird, A
- Merckelbach, A
- Müller-Neumann, M
- Riegel, J
- Starlinger, P
- Tillmann, E
Producer: 19850501
In:
Cold Spring Harbor symposia on quantitative biology vol. 49
Availability: No items available.
|
|
|
103.
|
|
|
|
104.
|
|
|
|
105.
|
Differentiated parietal connectivity of frontal regions for "what" and "where" memory. [electronic resource] by
- Rottschy, C
- Caspers, S
- Roski, C
- Reetz, K
- Dogan, I
- Schulz, J B
- Zilles, K
- Laird, A R
- Fox, P T
- Eickhoff, S B
Producer: 20140530
In:
Brain structure & function vol. 218
Availability: No items available.
|
|
|
106.
|
Pharmacokinetic characterization in xenografted mice of a series of first-generation mimics for HLA-DR antibody, Lym-1, as carrier molecules to image and treat lymphoma. [electronic resource] by
- DeNardo, Gerald L
- Natarajan, Arutselvan
- Hok, Saphon
- Perkins, Julie
- Cosman, Monique
- DeNardo, Sally J
- Lightstone, Felice C
- Mirick, Gary R
- Miers, Laird A
- Balhorn, Rodney L
Producer: 20070920
In:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine vol. 48
Availability: No items available.
|
|
|
107.
|
SU6668 inhibits Flk-1/KDR and PDGFRbeta in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice. [electronic resource] by
- Laird, A Douglas
- Christensen, Jmes G
- Li, Guangmin
- Carver, Jeremy
- Smith, Kimberly
- Xin, Xiaohua
- Moss, Katherine G
- Louie, Sharianne G
- Mendel, Dirk B
- Cherrington, Julie M
Producer: 20020506
In:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. 16
Availability: No items available.
|
|
|
108.
|
Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study. [electronic resource] by
- Tolaney, Sara M
- Nechushtan, Hovav
- Ron, Ilan-Gil
- Schöffski, Patrick
- Awada, Ahmad
- Yasenchak, Chris A
- Laird, A Douglas
- O'Keeffe, Bridget
- Shapiro, Geoffrey I
- Winer, Eric P
Producer: 20171207
In:
Breast cancer research and treatment vol. 160
Availability: No items available.
|
|
|
109.
|
In vivo measurement of regional large artery compliance by intravascular ultrasound under pentobarbital anesthesia. [electronic resource] by
- Wilson, R A
- Di Mario, C
- Krams, R
- Soei, L K
- Wenguang, L
- Laird, A C
- The, S H
- Gussenhoven, E
- Verdouw, P
- Roelandt, J R
Producer: 19950719
In:
Angiology vol. 46
Availability: No items available.
|
|
|
110.
|
|
|
|
111.
|
|
|
|
112.
|
Phase I safety and pharmacokinetic study of the PI3K/mTOR inhibitor SAR245409 (XL765) in combination with erlotinib in patients with advanced solid tumors. [electronic resource] by
- Jänne, Pasi A
- Cohen, Roger B
- Laird, A Douglas
- Macé, Sandrine
- Engelman, Jeffrey A
- Ruiz-Soto, Rodrigo
- Rockich, Kevin
- Xu, Jianbo
- Shapiro, Geoffrey I
- Martinez, Pablo
- Felip, Enriqueta
Producer: 20141021
In:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 9
Availability: No items available.
|
|
|
113.
|
Phase I safety, pharmacokinetic, and pharmacodynamic study of SAR245409 (XL765), a novel, orally administered PI3K/mTOR inhibitor in patients with advanced solid tumors. [electronic resource] by
- Papadopoulos, Kyriakos P
- Tabernero, Josep
- Markman, Ben
- Patnaik, Amita
- Tolcher, Anthony W
- Baselga, José
- Shi, Weiliang
- Egile, Coumaran
- Ruiz-Soto, Rodrigo
- Laird, A Douglas
- Miles, Dale
- Lorusso, Patricia M
Producer: 20150820
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 20
Availability: No items available.
|
|
|
114.
|
Co-activation based parcellation of the human frontal pole. [electronic resource] by
- Ray, K L
- Zald, D H
- Bludau, S
- Riedel, M C
- Bzdok, D
- Yanes, J
- Falcone, K E
- Amunts, K
- Fox, P T
- Eickhoff, S B
- Laird, A R
Producer: 20160811
In:
NeuroImage vol. 123
Availability: No items available.
|
|
|
115.
|
Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma. [electronic resource] by
- Wen, Patrick Y
- Omuro, Antonio
- Ahluwalia, Manmeet S
- Fathallah-Shaykh, Hassan M
- Mohile, Nimish
- Lager, Joanne J
- Laird, A Douglas
- Tang, Jiali
- Jiang, Jason
- Egile, Coumaran
- Cloughesy, Timothy F
Producer: 20160511
In:
Neuro-oncology vol. 17
Availability: No items available.
|
|
|
116.
|
Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent. [electronic resource] by
- Mendel, D B
- Laird, A D
- Smolich, B D
- Blake, R A
- Liang, C
- Hannah, A L
- Shaheen, R M
- Ellis, L M
- Weitman, S
- Shawver, L K
- Cherrington, J M
Producer: 20000725
In:
Anti-cancer drug design vol. 15
Availability: No items available.
|
|
|
117.
|
Diversity in the oxidation of substrates by cytochrome P450 2D6: lack of an obligatory role of aspartate 301-substrate electrostatic bonding. [electronic resource] by
- Guengerich, F Peter
- Miller, Grover P
- Hanna, Imad H
- Martin, Martha V
- Léger, Serge
- Black, Cameron
- Chauret, Nathalie
- Silva, José M
- Trimble, Laird A
- Yergey, James A
- Nicoll-Griffith, Deborah A
Producer: 20021003
In:
Biochemistry vol. 41
Availability: No items available.
|
|
|
118.
|
Phase I safety, pharmacokinetic, and pharmacodynamic study of SAR245408 (XL147), an oral pan-class I PI3K inhibitor, in patients with advanced solid tumors. [electronic resource] by
- Shapiro, Geoffrey I
- Rodon, Jordi
- Bedell, Cynthia
- Kwak, Eunice L
- Baselga, Jose
- Braña, Irene
- Pandya, Shuchi S
- Scheffold, Christian
- Laird, A Douglas
- Nguyen, Linh T
- Xu, Yi
- Egile, Coumaran
- Edelman, Gerald
Producer: 20140818
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 20
Availability: No items available.
|
|
|
119.
|
Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study. [electronic resource] by
- DeAngelo, Daniel J
- Stock, Wendy
- Stein, Anthony S
- Shustov, Andrei
- Liedtke, Michaela
- Schiffer, Charles A
- Vandendries, Erik
- Liau, Katherine
- Ananthakrishnan, Revathi
- Boni, Joseph
- Laird, A Douglas
- Fostvedt, Luke
- Kantarjian, Hagop M
- Advani, Anjali S
Publication details: Blood advances Jun 2017
In:
Blood advances vol. 1
Availability: No items available.
|
|
|
120.
|
Impact of minimal residual disease status in patients with relapsed/refractory acute lymphoblastic leukemia treated with inotuzumab ozogamicin in the phase III INO-VATE trial. [electronic resource] by
- Jabbour, Elias
- Gökbuget, Nicola
- Advani, Anjali
- Stelljes, Matthias
- Stock, Wendy
- Liedtke, Michaela
- Martinelli, Giovanni
- O'Brien, Susan
- Wang, Tao
- Laird, A Douglas
- Vandendries, Erik
- Neuhof, Alexander
- Nguyen, Kevin
- Dakappagari, Naveen
- DeAngelo, Daniel J
- Kantarjian, Hagop
Producer: 20200714
In:
Leukemia research vol. 88
Availability: No items available.
|